Splenic and perisplenic involvement in acute pancreatitis: determination of prevalence and morphologic helical CT features

PURPOSE

The purpose of this work was to determine the prevalence and morphologic helical CT features of splenic and perisplenic involvement in patients with acute pancreatic inflammatory disease in correlation with the severity of the pancreatitis.

METHOD

One hundred fifty-nine contrast-enhanced helical CT scans of 100 consecutive patients with acute pancreatitis were reviewed retrospectively and independently by three observers. CT scans were scored using the CT severity index (CTSI): Pancreatitis was graded as mild (0-2 points), moderate (3-6 points), and severe (7-10 points). Interobserver agreement for both the CTSI and the presence of splenic and perisplenic involvement was calculated (K statistic). Correlation between the prevalence of complications and the degree of pancreatitis was estimated using the Fisher exact test.

RESULTS

The severity of pancreatitis was graded as mild (n = 59 scans), moderate (n = 82 scans), and severe (n = 18 scans). Splenic and perisplenic abnormalities detected included perisplenic inflammatory fluid collections (95 scans, 58 patients), narrowing of the splenic vein (35 scans, 25 patients), splenic vein thrombosis (31 scans, 19 patients), splenic infarction (10 scans, 7 patients), and subcapsular hemorrhage (2 scans, 2 patients). No cases of splenic artery pseudoaneurysm formation, intrasplenic venous thrombosis, intrasplenic pseudocysts, or abscesses were detected. The interobserver agreement range for scoring the degree of pancreatitis and the overall presence of abnormalities was 75.5-79.2 and 71.7-100%, respectively. A statistically significant difference between the presence of abnormalities and the severity of pancreatitis was observed (p < 0.001).

CONCLUSION

Splenic vein thrombosis (19%) and splenic infarction (7%) are relatively common CT findings in association with acute pancreatitis. The CTSI proves to be accurate in predicting these complications as there is a statistically significant correlation between the prevalence of these complications and the severity of pancreatitis.

Multicentre dose-ranging study on the efficacy of USPIO ferumoxtran-10 for liver MR imaging

AIM

A dose ranging multicentre phase-II clinical trial was conducted to evaluate the efficacy of ultrasmall superparamagnetic iron oxide (USPIO) ferumoxtran-10 for magnetic resonance (MR) imaging of focal hepatic lesions.

MATERIAL AND METHODS

Ninety-nine patients with focal liver lesions received USPIO at a dose of 0.8 (n = 35), 1.1 (n = 32), or 1.7 (n = 32) mg Fe/kg. Liver MR imaging was performed before and after USPIO with T1-weighted and T2-weighted pulse sequences. Images were analysed by two independent readers for additional information (lesion detection, exclusion, characterization and patient management). Signal intensity (SI) based quantitative measurements were also taken.

RESULTS

Post-contrast medium MR imaging showed additional information in 71/97 patients (73%) for reader one and 83/96 patients (86%) for reader two. The results with all three doses were statistically significant (P < 0.05). Signal intensity analysis revealed that all three doses increased liver SI on T1-weighted images and decreased liver SI on T2-weighted images. On T2-weighted images metastases increased in contrast relative to normal hepatic parenchyma whereas haemangiomas decreased in contrast. On T2-weighted images there was statistically improved efficacy at the intermediate dose, which did not improve at the highest dose.

CONCLUSION

Ultrasmall superparamagnetic iron oxide was an effective contrast agent for liver MR imaging at all doses and a dose of 1.1 mg Fe/kg was recommended for future clinical trials.

Characterization of focal hepatic lesions with ferumoxides-enhanced T2-weighted MR imaging

OBJECTIVE

The purpose of this study was to evaluate whether ferumoxides-enhanced MR imaging of focal hepatic lesions provides distinctive signal intensity and lesion-to-liver contrast changes for benign and malignant lesions, helping to further characterize and differentiate these lesions.

MATERIALS AND METHODS

Data analysis was performed on 70 patients, with previously identified focal hepatic lesions, who underwent MR imaging of the liver before and after IV administration of ferumoxides (10 micromol Fe/kg). Lesions analyzed with pathologically proven diagnoses included metastases (n = 40), hepatocellular carcinoma (n = 11), cholangiocarcinoma (n = 6), hemangioma (n = 4), focal nodular hyperplasia (n = 6), and hepatocellular adenoma (n = 3). Response variables measured and statistically compared included the percentage of signal-intensity change and lesion-to-liver contrast.

RESULTS

Focal nodular hyperplasia showed significant signal intensity loss on ferumoxides-enhanced T2-weighted images (mean, -43%+/-6.7%, p < 0.01). All other lesion groups showed no statistically significant change in signal intensity on ferumoxides-enhanced T2-weighted images, although signal intensity loss was seen in some individual hepatocellular adenomas (mean, -6.6%+/-24.0%) and hepatocellular carcinomas (mean, -3.3%+/-10.3%). All lesions, with the exception of hepatocellular carcinoma, had a marked increase in lesion-to-liver contrast on ferumoxides-enhanced T2-weighted images, which was statistically significant for metastases and hemangioma (p < 0.02).

CONCLUSION

Focal nodular hyperplasia shows significant decrease in signal intensity on ferumoxides-enhanced T2-weighted images, which may aid in the differentiation of focal nodular hyperplasia from other focal hepatic lesions. Other lesions, namely, hepatocellular adenoma and carcinoma, can have reticuloendothelial uptake, but usually to a lesser degree than that of focal nodular hyperplasia.

Renal and perirenal space involvement in acute pancreatitis: spiral CT findings

BACKGROUND

This study was conducted to estimate the prevalence and morphologic computed tomographic (CT) features of renal and perirenal space abnormalities in acute pancreatitis in correlation with the severity of pancreatitis.

METHODS

One hundred fifty-nine contrast-enhanced CT scans of 100 consecutive patients with acute pancreatitis were retrospectively and independently reviewed by three observers. All CT images were obtained using contrast-enhanced helical CT (collimation width = 5 mm, table increment = 7 mm/s, reconstruction interval = 5 mm, scan delay time = 30-50 s). Additional maximized images (field of view = 260 mm) of the perirenal space were available for review. All CT scans were scored with the CT Severity Score Index: pancreatitis was graded as mild (0-2 points), moderate (3-6 points), and severe (7-10 points). Interobserver agreement for both the severity score and the presence of renal and perirenal involvement was calculated. Correlation between the prevalence of complications and the degree of pancreatitis was estimated.

RESULTS

CT scans were graded as mild (n = 59), moderate (n = 82), and severe (n = 18). Abnormalities detected included perirenal stranding (n = 37 patients, 26 bilateral), perirenal fluid collections (n = 10 patients, one bilateral), ureteral encasement (n = 2 patients), renal vein thrombosis (n = 1 patient), and renal parenchymal abnormalities (n = 1 patient). The interobserver agreement range for scoring the degree of pancreatitis and the overall presence of abnormalities was 75.5-79.2% and 59.8-100%, respectively. Except for stranding of the perirenal fat, no statistically significant differences between the presence of abnormalities and the severity of pancreatitis (moderate or severe) was observed with Fisher's exact test. Also, no preferential left-sided localization of complications was observed.

CONCLUSIONS

The incidence of renal and perirenal complications from acute pancreatitis is higher than previously estimated (7%). We found no significant correlation between the prevalence of major complications and the severity of pancreatitis. These findings are important because these complications may have an impact on therapeutic strategy and can affect prognosis.

Perineal angiomyofibroblastoma: CT and MR findings with pathologic correlation

We present a case of a perineal angiomyofibroblastoma (AMFB) arising in the right perirectal fossa in a middle-aged woman, documented with CT and MRI. Compounding the rarity of the entity, this case is unique as it is the first radiological report illustrating the CT and MR features of this recently clinicopathologically described neoplasm.

Pediatric liver neoplasms: a radiologic-pathologic correlation

Only 1-2 % of all pediatric tumors occur in the liver. Two thirds of these tumors are malignant and almost all of the tumors cause clinical symptoms due to their mass effects. Besides the poor prognosis in most of the malignant tumors, for further treatment the origin and nature of the neoplasm has to be known. Due to the mostly unimpeded growth into the peritoneal cavity, the origin of the tumors is primarily often unclear and can non-invasively only be determined by advanced imaging techniques. The display of the macro- and microhistological key features of primary pediatric liver neoplasms, including hepatoblastoma (HB), infantile hemangioendothelioma (IHE), mesenchymal hamartoma (MH), undifferentiated (embryonal) sarcoma (UES), and hepatocellular carcinoma (HCC), together with their imaging representation by ultrasound, computed tomography, and magnetic resonance imaging, may deepen the understanding of the underlying pathology and its imaging appearance. Furthermore, in many cases sufficient information may be provided not only to differentiate benign from malignant tumors, but also to guide for adequate treatment.

Bilateral adrenal cystic lymphangiomas in nevoid basal cell carcinoma (Gorlin-Goltz) syndrome: US, CT, and MR findings

We present a case of bilateral adrenal cystic lymphangioma in a patient with the Gorlin-Goltz syndrome. This case is unique as it is the first illustrated case (US, CT, and MR findings) of a cystic lymphangioma arising within the adrenal gland. In addition, the coexistence of cystic adrenal lymphangioma with the Gorlin-Goltz syndrome has not been described previously.

New formula for quantification of pleural effusions from computed tomography

The authors develop a method to accurately and easily estimate the volume of pleural effusions with computed tomography (CT). In 15 patients with either simple or loculated pleural effusions (14 right-sided and 11 left-sided), routine helical CT examinations of the thorax were obtained. Two experienced radiologists visually estimated the volume of the effusions. Three-dimensional reconstructions of the pleural effusions were performed from the helical CT examinations, and the volumes of the effusions were calculated. Effusion volumes were also estimated using the formula d2 x l (d = greatest depth of the effusion on a single CT image, l = greatest length of the effusion). The computer calculated the estimated volumes and they were then statistically compared. The coefficient of correlation between the estimation by measurement and calculated volumes of all effusions was 0.908 (p<0.0001) for the right side, and 0.849 for the left side (p<0.002). Excluding the loculated effusions, the coefficient of correlation was 0.969 for the right side and 0.949 for the left side (p<.001). The volume estimation by visual inspection was also correlated to the calculated volumes (0.84 on the left and 0.85 on the right, p<0.008), but resulted in a consistent overestimation by 300 ml to 500 ml. Although pleural effusion volumes can be estimated by visual inspection with good correlation, some overestimation is consistently seen. Use of the formula d2 x l readily enables estimation of pleural effusion volume from CT, from two simple measurements. This formula-based method of volume estimation provides an accurate and easily measured means of estimation that is readily obtained from routine CT of the chest.

Image mottle in abdominal CT

RATIONALE AND OBJECTIVES

To investigate image mottle in conventional CT images of the abdomen as a function of radiographic technique factors and patient size.

METHODS

Water-filled phantoms simulating the abdomens of adult (32 cm in diameter) and pediatric (16 cm in diameter) patients were used to investigate image mottle in CT as a function of x-ray tube potential and mAs. CT images from 39 consecutive patients with noncontrast liver scans and 49 patients with iodine contrast scans were analyzed retrospectively. Measurements were made of the mean liver parenchyma Hounsfield unit value and the corresponding image mottle.

RESULTS

For a given water phantom and x-ray tube potential, image mottle was proportional to the mAs-0.5. Increasing the phantom diameter from 16 cm (pediatric) to 32 cm increased the mottle by a factor of 2.4, and increasing the x-ray tube potential from 80 kVp to 140 kVp reduced the mottle by a factor of 2.5. All patients were scanned at 120 kVp, with no correlation between patient size and the x-ray tube mAs. The mean mottle level was 7.8 +/- 2.2 and 10.0 +/- 2.5 for the noncontrast and contrast studies, respectively. An increase in patient diameter of 3 cm would require approximately 65% more mAs to maintain the same level of image mottle.

CONCLUSIONS

The mottle in abdominal CT images may be controlled by adjusting radiographic technique factors, which should be adjusted to take into account the size of the patient undergoing the examination.

Fibrolamellar carcinoma of the liver: radiologic-pathologic correlation

Fibrolamellar carcinoma is a malignant hepatocellular tumor with distinct clinical and pathologic differences from hepatocellular carcinoma. It differs from hepatocellular carcinoma in demographics, condition of the affected liver, tumor markers, and prognosis. Fibrolamellar carcinoma characteristically manifests as a large hepatic mass in adolescents or young adults (without gender predominance). Cirrhosis; elevated alpha-fetoprotein levels; and typical risk factors for hepatocellular carcinoma such as viral hepatitis, alcohol abuse, and metabolic disease are typically absent. Fibrolamellar carcinoma is characterized pathologically by cords of tumor cells surrounded by abundant collagenous fibrous tissue arranged in a parallel or lamellar distribution. Fibrotic lamellae often coalesce to form a central scar. Fibrolamellar carcinoma characteristically appears on radiologic images as a lobulated heterogeneous mass with a central scar in an otherwise normal liver. Radiologic evidence of cirrhosis, vascular invasion, or multifocal disease--findings typical of hepatocellular carcinoma--is uncommon in fibrolamellar carcinoma. Imaging features of fibrolamellar carcinoma overlap with those of other scar-producing lesions including focal nodular hyperplasia (FNH), hepatocellular adenoma and carcinoma, hemangioma, metastases, and cholangiocarcinoma. FNH, in particular, may simulate fibrolamellar carcinoma, since both have similar demographic and clinical characteristics. Because some believe that radiologic diagnosis of FNH is possible, it is important to understand the imaging appearance of fibrolamellar carcinoma to avoid misdiagnosing this malignant tumor as a FNH.

Safety profile of ultrasmall superparamagnetic iron oxide ferumoxtran-10: phase II clinical trial data

The safety data from the phase II clinical trial of ferumoxtran-10, an ultrasmall superparamagnetic iron oxide contrast agent, are presented. One hundred and four patients with focal liver or spleen pathologies underwent ferumoxtran-10-enhanced magnetic resonance (MR) imaging at doses of 0.8, 1.1, and 1.7 mg Fe/kg. Overall, 15% patients reported a total of 33 adverse events, regardless of causality. The adverse events most frequently seen were dyspnea (3.8%), chest pain (2.9%), and rash (2.9%). No serious adverse events were reported during the 48 hour observation period. There were no clinically significant effects on vital signs, physical examination, and laboratory results. Ferumoxtran-10 is a safe and well tolerated MR contrast agent.

MRI in focal liver disease: a comparison of small and ultra-small superparamagnetic iron oxide as hepatic contrast agents

The purpose of this study was to compare small and ultrasmall superparamagnetic iron oxide particles (SPIO and USPIO, respectively) as MR contrast agents for the evaluation of focal hepatic disease. In two different patient groups (SPIO [n = 53], USPIO [n = 27]), with focal liver disease (metastases, hepatocellular carcinoma [HCC], hepatocellular adenoma [HCA], and focal nodular hyperplasia [FNH]), spin-echo T1- and T2-weighted images (T1WI, T2WI) were obtained at 1.0T, before and after intravenous contrast administration. The percentage signal-to-noise ratio (SNR) change and lesion-to-liver contrast (LLC) were measured and statistically compared. The liver decreased in signal intensity (SI) after SPIO administration (-28%) and increased after USPIO administration (+16%) on T1WI. On T2WI, the liver decreased in SI on postcontrast images with both agents (-78% SPIO, -73% USPIO). This difference was not statistically significantly different (P < or = .07). Both SPIO and USPIO provided >500% improvement in LLC on T2WI. On T1WI, LLC was increased in metastases (120%) and HCC (325%) with SPIO. Post-USPIO, LLC was increased on T1WI only in metastases (>500%). Both SPIO and USPIO show excellent hepatic uptake, presumed secondary to reticuloendothelial activity, based on the degree of %SI change seen in the liver after administration of contrast on T2WI. However, USPIO preparations exhibit blood pool activity that may aid in further characterization of focal liver lesions, as is evidenced by their greater T1 effect in the liver and in some focal liver lesions.

Dynamic gadolinium-enhanced MR findings in infantile hepatic hemangioendothelioma

We report a case of a 2 1/2-year-old girl presenting with abdominal pain, fever, vomiting, and hepatomegaly. In spite of the unusual age at presentation, dynamic gadolinium-enhanced MR findings, which have not been previously illustrated, proved to be highly specific for the diagnosis of infantile hepatic hemangioendothelioma because of the characteristic enhancement pattern.

Three-dimensional volumetric assessment of abnormally low attenuation of the lung from routine helical CT: inspiratory and expiratory quantification

OBJECTIVE

The purpose of this investigation was to quantitatively assess abnormally low attenuation of the lung by use of three-dimensional volumetric reconstructions from routine helical CT and to assess their correlation with pulmonary function tests.

MATERIALS AND METHODS

Helical CT was performed in 100 patients in full inspiration. Examination was also performed in full expiration in 53 of these patients. Three-dimensional volumetric reconstructions were performed for total lung volumes at inspiration and at expiration, with a threshold of -896 H on inspiratory CT and -790 H on expiratory CT, to quantify emphysematous change. Correlation was made with pulmonary function tests in 79 patients.

RESULTS

CT volumetric assessments of abnormally low attenuation of the lung at inspiration and expiration had a high correlation (r2 = .84, p < or = .0001). In comparison with pulmonary function tests, both inspiratory low attenuation of the lung and expiratory low attenuation of the lung correlated well with the logarithm of the ratio of the forced expiratory volume in 1 sec (FEV1) to the forced vital capacity (r2 = .74, p < or = .0001 and r2 = .74, p < or = .0001, respectively) and with the percentage of predicted ratio of the FEV1 to the forced vital capacity (r2 = .69, p < or = .0001 and r2 = .69, p < or = .0001, respectively). Linear correlations were also seen with FEV1, residual volume, and forced residual capacity.

CONCLUSION

Three-dimensional volumetric reconstructions of hypoattenuating lung correlate well with pulmonary function tests. In addition, inspiratory and expiratory data are also correlative, suggesting that a dedicated expiratory examination is not needed. This easily obtainable information will prove useful for patients with obstructive lung disease from emphysema, providing a measure of pulmonary function status in this population.

The Rocky liver: radiologic-pathologic correlation of calcified hepatic masses

Although relatively uncommon in daily clinical practice, calcification may be found in inflammatory hepatic lesions and in benign and malignant liver neoplasms. The most common source of calcified hepatic lesions is inflammatory conditions such as granulomatous diseases (e.g., tuberculosis). The calcification typically involves the entire lesion and appears as a dense mass that can produce artifacts on computed tomographic (CT) scans. Echinococcus cysts have curvilinear or ring calcification. Hemangiomas, especially large ones, may contain large, coarse calcifications that are centrally located in areas of fibrosis; these may be seen at CT (20% of cases) or radiography (10%). In hepatocellular adenoma, calcifications may be solitary or multiple and are usually located eccentrically within a complex heterogeneous mass. Calcifications in fibrolamellar carcinoma have been reported in 15%-25% of cases at CT and occur in a wide variety of patterns. Calcifications in intrahepatic cholangiocarcinoma are typically accompanied by a desmoplastic reaction and are visible at CT in about 18% of cases. Calcified hepatic metastases are most frequently associated with mucin-producing neoplasms such as colon carcinoma. Knowledge of the pathologic features of each entity helps radiologists to better recognize the shape, size, density, number, location, and distribution of hepatic calcifications seen on images and to narrow the differential diagnosis.

Improved technique for pancreatic MRI: value of oblique fat suppression imaging with oral barium administration

PURPOSE

Our goal was to determine the efficacy of a dedicated protocol for pancreatic MRI using fat suppression, oblique plane orientation, and barium as an oral contrast agent.

METHOD

Fifty-two patients were enrolled in our study. In each patient, the stomach and duodenum were opacified with 300 ml oral barium. In all patients conventional SE T1- and T2-weighted images and fat-suppressed axial and oblique T1-weighted images of the upper abdomen and the pancreas, respectively, were obtained. The different T1-weighted sequences were compared for visualization of the pancreas and for lesion conspicuity. Oblique images were obtained in a plane parallel to the overall axis of the pancreas. All sequences were qualitatively assessed by two independent blinded readers and statistically compared.

RESULTS

The combination of fat suppression and oblique imaging significantly improved the visualization of the different anatomic portions of the normal pancreas as well as pathologic findings in the pancreas in 70-92% of the cases compared with conventional axial T1-weighted imaging (p < 0.001) and in 52-75% of the cases compared with axial fat-suppressed T1-weighted imaging (p < 0.001), respectively. Increased image noise and blurring artifacts resulted in slight image degradation after Gd-DTPA administration. Barium as a duodenal contrast agent was beneficial for delineation of the pancreatic head from the adjacent bowel structures.

CONCLUSION

In pancreatic imaging, fat-suppressed T1-weighted imaging is superior to conventional T1-weighted imaging, and oblique imaging is superior to axial imaging. Intravenous Gd-DTPA administration was useful only in selected cases.

MRI of the rectum: non-neoplastic disease

The rectum has become the most successful area of the gastrointestinal tract to be studied with MRI. Its anatomical location, fixed in the pelvic fat, and its lack of peristalsis, make it an ideal organ to be scanned with MRI. In addition, MRI allows a direct sagittal and coronal display, of key importance to colorectal surgeons whose terminology and approach are based on the coronal plane. The sagittal plane allows the depiction of the relation of the rectum to the sacrum, uterus and prostate, with detail not available by other imaging techniques, and the use of endorectal coils allows excellent demonstration of the rectal wall. Although MRI has been used primarily to study rectal carcinoma, other diseases, congenital, inflammatory and vascular in origin, can be studied using the correct technique.

Hepatic calcification

Although a specific diagnosis of the calcified liver mass may not always be possible, there are some morphologic imaging features that help to indicate the diagnosis (Table 1). The radiologist needs to be aware of the wide spectrum of diseases of the liver that can calcify, and the most common causes. Pathologic correlation with axial imaging has greatly enhanced our understanding and interpretation of the underlying liver lesion, which may help to differentiate benign from malignant etiology.

Hepatic metastases

Developments in ultrasound, CT scan, and MR imaging have increased our ability to detect and characterize focal liver lesions. Advances in the medical and surgical treatment of secondary liver tumors have continued to challenge these advances in radiology. A successful outcome depends on knowledge of the size and location of the tumor burden, and accurate radiologic assessment is crucial to identify those subgroups who may benefit from surgery and to prevent unnecessary radical surgery in those likely to gain only a short-term benefit.

Benign lesions of the liver

Although many hepatic lesions can overlap significantly in their imaging appearance, an imaging approach that is based upon identifying the pathologic and functional components of a lesion can aid in distinction from other entities. In this manner, the diagnostic evaluation can be tailored using the appropriate imaging modality for the lesion at hand. An understanding of the benign liver lesions based on the cellular line of origin and subsequent functional components aids in grasping their expected imaging appearance and may aid in their distinction from malignant tumors. Thus, an imaging approach leading to diagnosis of these tumors should be based on this underlying knowledge of the functional components and cells within the lesion to be studied. For lesions with Kupffer's cell activity, such as FNA, Tc-99m sulfur colloid scan or MR imaging with SPIO may yield the most diagnostic information. For lesions such as hepatic cysts or angiomyolipoma, the diagnosis is usually not a dilemma. For hemangiomas, the most commonly encountered benign hepatic lesion, distinction from other entities may be readily apparent from the initial CT scan or US examination, or it may require additional evaluation with MR imaging. Finally, for other lesions with many cellular components, such as HCA, the imaging findings may not be specific enough by any modality to preclude tissue diagnosis. In any case, it is important to know the diagnostic accuracy and limitations of the imaging modalities available for assessment of any given benign hepatic mass.